Magnetar Financial LLC raised its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 23.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,350,598 shares of the company’s stock after buying an additional 441,265 shares during the period. Option Care Health comprises about 1.3% of Magnetar Financial LLC’s portfolio, making the stock its 23rd largest holding. Magnetar Financial LLC owned approximately 1.38% of Option Care Health worth $54,534,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP boosted its holdings in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after purchasing an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
OPCH has been the topic of several recent research reports. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. UBS Group initiated coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $33.00.
Option Care Health Stock Up 0.6 %
OPCH stock opened at $34.52 on Thursday. The firm has a market cap of $5.71 billion, a PE ratio of 29.01, a PEG ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm’s 50 day moving average price is $31.43 and its 200-day moving average price is $28.29. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.85.
Insider Buying and Selling at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is owned by corporate insiders.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
- Five stocks we like better than Option Care Health
- How to Effectively Use the MarketBeat Ratings Screener
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Consumer Staples Stocks, Explained
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Dividend Payout Ratio Calculator
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.